Tag: education

Where in the World is Marijuana Legal?

When it comes to cannabis, every country has its own special relationship with the herb. Acceptance of marijuana ranges from “we respect your right to partake” to “we’re sentencing you to life in prison.”

Everybody knows Amsterdam is cool with the ganja. Ok, technically cannabis is illegal in the Netherlands, but we’ll get into the nitty-gritty on that later. But did you know you can smoke, sell, and cultivate cannabis in North Korea? Yeah. Weird, right?

We knew you’d want to know more because “where is weed legal” is one of the most frequently searched cannabis-related phrases in Google. So, pack a bowl (if you’re in a legal state or country), sit back, and enjoy our deep dive into marijuana legality around the globe.*

MJ World Legality Infographic

Toking up around the world

Uruguay was the first country to legalize marijuana in 2013. Residents are free to cultivate, consume, and distribute cannabis without punishment and the country recently allowed the sale of cannabis in local pharmacies. Tourists, however, need to be in tight with a resident to get their hands on the green in Uruguay.

Canada nationally legalized marijuana in 2017 and is crafting regulations to have a system for the legal cultivation, sale, and consumption of cannabis for adults in place by July 2018 so adults over the age of 18 can legally possess up to 30 grams of dried flower. Individual provinces can decide to raise the legal minimum age. A medical cannabis program run by Health Canada called the Access to Cannabis for Medical Purposes regulations outlines specific conditions that allow medical patients access to cannabis medicine.

Costa Ricans are allowed to have a “small amount” of marijuana. But there is no specific guideline that states exactly how much constitutes a “small amount.” In late 2016, the Costa Rican Legislative Assembly drafted a medical marijuana bill, titled the “Law for the Investigation, Regulation, and Control of Cannabis and Hemp for Medicinal, Food, and Industrial Use,” which is still undergoing revision.

Peru allows you to possess marijuana without repercussions as long as it’s for personal, private, and immediate use. In February, the Peruvian Congressional Committee on National Defense signed off on legislation to officially legalize the use of medical marijuana. Last week, the country’s Congress passed a medical marijuana bill by a vote of 68-5 that would allow production, imports, and sales of cannabis-derived oil. President Pedro Pablo Kuczynski is expected to sign the bill into law.

Spain respects the rights of private citizens to grow and consume cannabis. Thanks to this “you do you” philosophy, Spain has more than 800 dispensaries or private social clubs where enthusiasts lucky enough to get an invitation can consume cannabis while socializing with friends old and new. Just don’t get caught selling it. Cannabis distribution is not tolerated. Catalonia legalized cannabis this year.

In the Netherlands, marijuana is still illegal. But as long as you’re not bothering anyone, officials generally turn a blind eye. In Amsterdam, however, social use is perfectly acceptable thanks to a provision that allows for “coffeeshops,” where both residents and visitors can purchase cannabis products for on-site — and even outdoor — consumption.

Not legal, but generally accepted

Recreational and medical cannabis users in Germany have little to worry about when it comes to possession and consumption. Recreational users may face a fine if caught, but no criminal penalties. And their medical marijuana program requires insurers to cover the cost of products for patients with severe conditions.

Jamaica has long been known as a place where you can find ganja, but it wasn’t until 2015 that cannabis was actually decriminalized in the country. Individuals caught with 2 ounces or less face a $5 fine. This year, the country introduced its medical marijuana program. Visitors to Jamaica who have legitimate medical prescriptions from their place of residence can acquire a cheap permit to purchase and use medical marijuana while visiting the island.

If you’re in Portugal, small quantities of all drugs for personal consumption are considered non-criminal and you can safely carry and consume cannabis privately. You may still get fined or be given orders for rehabilitation if caught, but when it comes to practice, such cases are usually suspended. Do not grow it, however. Cultivation is illegal — even cannabis seeds are prohibited.

In Argentina, it’s OK to consume cannabis, but it’s illegal to sell, transport, or cultivate the herb. When it comes to medical marijuana, however, cannabis is available to qualified patients for free. In India, you can drink Bhang, a cannabis drink, but no other cannabis use is tolerated.

Visiting the Czech Republic? Medical cannabis is legal for locals and in many urban areas, Mary Jane is considered a low priority to authorities as long as you’re not consuming it in public.

In Australia, it depends on where you are. Some Australian states have decriminalized marijuana while others enforce strict punishments for possession. Medical marijuana is allowed in very limited cases and the criteria vary by region. Personal use is decriminalized in the Northern Territory, South Australia, and the Australian Capital Territory.

Ecuador has decriminalized the personal use of up to 10 grams. While in Italy, medical and religious consumption is OK, but personal use — even small amounts — can net you a misdemeanor.

In Mexico, up to 5 grams of cannabis is decriminalized. In 2016, Mexico’s Senate approved a bill that would allow medical marijuana use by adults, which the Lower House of Congress passed in April of this year. President Enrique Peña Nieto signed the legalization decree in June.

Estonia doesn’t mess around. Possession of up to 7.5 grams for personal use is OK, but any more than that and you face up to five years in jail.

Up to 5 grams of cannabis is decriminalized in Austria while in Belgium, you can possess up to 3 grams without criminal penalty. Other countries that have decriminalized small amounts of cannabis include Bolivia, Brazil, Chile, Costa Rica, Croatia, Georgia, Greece, Italy Luxembourg, Malta, Moldova, Paraguay, Russia, Slovenia, Ukraine, and the Virgin Islands.

While the cultivation, sale, and use of cannabis is illegal in Switzerland, possession is decriminalized for small amounts. Products that contain less than one percent THC are allowed.

In Cambodia, it’s common practice for police to look the other way if locals are found in possession of cannabis and Israeli citizens can possess small amounts of cannabis without a criminal penalty. Smoking in public, however, is not tolerated and carries a fine.

No matter where you travel, be sure to familiarize yourself with the legality of cannabis and the full risks associated with its possession or consumption in that country.

* This is not an exhaustive list — that would be really long and you wouldn’t read it.


Start a Marijuana Business Today: CertificationClinics.com™ offers a comprehensive business model for recommending Medical Marijuana Certifications and/or Dispensary Ownership in your area. The CertificationClinics.com™ Business Support staff will educate you in every of the growing medical marijuana industry, providing you a fully operational and profitable enterprise. Learn More »

Know Your Medicine: CBG and CBGA

Experts report that there are at least 106 phytocannabinoids found in the trichomes of the cannabis flower. Most research has focused on the two most prominent “primary” cannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). However, many of the so-called “secondary” cannabinoids are responsible for adding to the therapeutic effects of cannabis as part of the entourage effect, the term used to describe how the many cannabinoid and terpenoid compounds in cannabis work synergistically to deliver beneficial effects.

Cannabinoid Biosynthesis Part 1 – CBG, THC, CBD, and CBC

Cannabinoid Biosynthesis Part 1 – CBG, THC, CBD, and CBC

Cannabigerol (CBG) and cannabigerolic acid (CBGA) are two of the many secondary phytocannabinoids found in the flower of the cannabis plant. The “A” in CBGA refers to the presence of a certain chemical structure called carboxylic acid.  CBG was initially isolated from hash by Israeli researchers in 1964, with subsequent research in Japan elucidating that CBGA was its precursor. CBG is one of the five most common cannabinoids along with THC, CBD, CBN (cannabinol) and CBC (cannabichromene). CBGA plays an extremely important role as the parent compound in the maturing cannabis flower and undergoes a number of changes to create THC, CBD, CBC, and CBG. This process, called biosynthesis, starts when compounds in the maturing flower, geranyl pyrophosphate and olivetolic acid, bond together to create CBGA. Next, CBGA is exposed to three different enzymes, with the amount of each enzyme determined by the genetics of the plant.

  • The enzyme THCA synthase converts CBGA to THCA
  • The enzyme CBDA synthase converts CBGA to CBDA
  • The enzyme CBCA synthase converts CBGA to CBCA

As you can see in the chart below, all of the “A” forms are converted in a process called decarboxylation. CBGA itself converts to CBG when heated.  


There is scant research on the medicinal benefits of CBGA. In the plant, CBGA provides a defense mechanism, along with THCA, as an insecticidal agent. When released from the trichomes of the cannabis plant, CBGA, THCA, CBCA and CBDA can each produce plant cell necrosis which allows for natural fan leaf pruning. This allows for the plant to direct its energy away from the leaves to the flower.

Medicinal Properties of CBG

CBG is non-intoxicating and has the following medicinal properties, demonstrated in laboratory and animal studies:

  • Antifungal
  • Antibacterial with potent inhibition of MRSA
  • Anticancer (skin, prostate, and breast)
  • Antidepressant in animal models
  • Mild antihypertensive (lowers blood pressure)
  • Inhibits growth of certain skin cells that contribute to psoriasis
  • Blocks uptake of GABA, promoting muscle relaxation
  • Lowers intraocular eye pressure
  • Enhanced appetite
  • Neuroprotection

CBG is present in small amounts in the vast majority of drug-variety cannabis plants. However, it is more abundant in fiber variety plants (aka “hemp”). Recent breeding experiments in Europe have resulted in fiber variety cannabis containing a significant predominance of CBG, with content >80% in some. With the widespread legalization of cannabis for medical and recreational use underway, growers have the opportunity to focus on breeding CBG-rich varieties of cannabis paralleling the recent explosion of CBD-rich varieties. Having a broad array of products with a variety of dominant cannabinoids will allow for patients to customize their cannabis regimen to suit their individual needs.  


Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M  et al. (2008). Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. J Nat Prod  71: 14271430.

Baek SH, Kim YO, Kwag JS, Choi KE, Jung WY, Han DS (1998). Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells. Arch Pharm Res  21: 353–356.

Banerjee SP, Snyder SH, Mechoulam R (1975). Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes. J Pharmacol Exp Ther  194: 74–81.

Brierley, Daniel I., et al. “Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.” Psychopharmacology 233.19-20 (2016): 3603-3613.

Cascio MG, Gauson LA, Stevenson LA, Ross RA, Pertwee RG (2010). Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Br J Pharmacol  159: 129–141.

Colasanti, Brenda K. “A comparison of the ocular and central effects of Δ9-tetrahydrocannabinol and cannabigerol.” Journal of Ocular Pharmacology and Therapeutics 6.4 (1990): 259-269.

De Petrocellis L, Di Marzo V (2010). Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. J Neuroimmune Pharmacol  5: 103–121.

ElSohly HN, Turner CE, Clark AM, ElSohly MA (1982). Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds. J Pharm Sci  71: 1319–1323.

Evans FJ (1991). Cannabinoids: the separation of central from peripheral effects on a structural basis. Planta Med  57: S60–S67.

Formukong EA, Evans AT, Evans FJ (1988). Analgesic and antiinflammatory activity of constituents of Cannabis sativa L. Inflammation  12: 361–371.

Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L  et al. (2006). Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther  318: 1375–1387.

Maor Y, Gallily R, Mechoulam R (2006). The relevance of the steric factor in the biological activity of CBD derivaties-a tool in identifying novel molecular target for cannabinoids. In: Symposium on the Cannabinoids. International Cannabinoid Research Society: Tihany, Hungary, p. 1.

Musty R, Deyo R (2006). A cannabigerol extract alters behavioral despair in an animal model of depression. Proceedings June 26; Symposium on the Cannabinoids. International Cannabinoid Research Society: Tihany, p. 32.

Shoyama, Yukihiro, et al. “Biosynthesis of cannabinoid acids.” Phytochemistry 14.10 (1975): 2189-2192.

Sirikantaramas, Supaart, et al. “Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes.” Plant and Cell Physiology 46.9 (2005): 1578-1582.

Taura, Futoshi, et al. “First direct evidence for the mechanism of. DELTA. 1-tetrahydrocannabinolic acid biosynthesis.” Journal of the American Chemical Society 117.38 (1995): 9766-9767.

Valdeolivas, Sara, et al. “Neuroprotective properties of cannabigerol in Huntington’s disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice.” Neurotherapeutics 12.1 (2015): 185-199.

Wilkinson JD, Williamson EM (2007). Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatol Sci  45: 87–92.


Start a Marijuana Business Today: CertificationClinics.com™ offers a comprehensive business model for recommending Medical Marijuana Certifications and/or Dispensary Ownership in your area. The CertificationClinics.com™ Business Support staff will educate you in every of the growing medical marijuana industry, providing you a fully operational and profitable enterprise. Learn More »

Arizona Marijuana: Everything to Know About Marijuana Law in AZ

Brandi Atkins, an Arizona resident and former dancer, was diagnosed in late 2015 with a rare autoimmune disease that made her joints and muscles swell, causing chronic pain. She popped in and out of the hospital with a cornucopia of prescription medications handed out to alleviate her pain, ease her symptoms, and navigate around her type 1 diabetes. These medications would often clash with her disease and cause her blood sugar to soar. In desperation, she turned to medical marijuana.

Almost immediately, Adkins noticed an improvement in balance, palatable reduction in pain, and (most importantly) hope for her future. The dispensary she visited took the time to understand her specific concerns, her goals, and the particulars of her health conditions. Thanks to medical marijuana, Adkins feels like she can dance again.

This hopeful scenario plays out in dispensaries across Arizona, where more than 100,000 patients suffering everything from epilepsy to chronic pain find relief through medical marijuana.

It’s an interesting situation: legalized medical marijuana and dispensaries in one of the United States’ most conservative territories. How do these conflicting events coexist? Have you ever wondered what exactly is the state of medical marijuana affairs in Arizona? Here’s our in-depth explanation of everything you always wanted to know about Arizona’s Medical Marijuana Laws (but were too afraid to ask).

The road to marijuana legalization in Arizona

When the federal government originally passed the Marihuana Tax Act of 1937, the predecessor to the Controlled Substances Act of 1970, all American states had criminalized cannabis in one way or another. It wasn’t until the mid-1990s that Arizona state legislators began listening to decades-long calls for marijuana law reform.

In 1996, Arizona passed Proposition 200, allowing doctors to prescribe medical marijuana (specifically, controlled substances) to treat diseases or relieve pain in seriously/terminally ill patients. In order for a patient to use medical marijuana, a doctor had to provide scientific evidence to prove marijuana’s usefulness along with a second doctor’s opinion to the Arizona Department of Health Services. This caused conflict between supporters and opponents of medical marijuana, and started a lengthy battle over the law’s lack of specificity in addition to the language “prescribe.” For a doctor to prescribe medicine, the substance must first undergo FDA trials and doctors must specify the exact dosage and consumption methods to be used. Unfortunately, this rendered Prop 200 illegal on a federal scope and a medical marijuana program never materialized. It did, however, protect first-time drug offenders from prison sentences, which was a step towards decriminalization.

Arizona tried once more to legalize medical marijuana in 2002 with Proposition 203, but the initiative failed, receiving 42.7% of the vote. A viable solution was not presented and approved until nearly a decade later.

In 2010, Arizonans voted to approve a much-revised version of Proposition 203, an initiative to legalize the medicinal use of marijuana. Proposition 203 authorized doctors to recommend cannabis as a therapeutic option, as opposed to prescribing a specific dosage of cannabis with strict consumption or application methods. This law also tasked the Arizona Department of Health Services (ADHS) to regulate the “Arizona Medical Marijuana Act.”

Arizona’s current marijuana policy

The ADHS had until April 2012 to establish a registration application system for patients and nonprofit marijuana dispensaries, as well as a web-based verification platform for use by law officials and dispensaries to verify a patient’s status as such. It also specified patients’ rights, qualifying medical conditions, and allowed out-of-state medical marijuana patients to maintain their patient status (though not to purchase cannabis).

On December 6, 2012, Arizona’s first licensed medical marijuana dispensary opened in Glendale.

In 2012, Arizona legislators amended the Arizona Medical Marijuana Act to include college and university campuses in their non-consumption list, even if the cardholder was over 21 years old. However, in April 2017, this ruling was overturned by the Arizona Court of Appeals, and though colleges can privately prohibit medical marijuana on campus, lawmakers cannot make campus cannabis use illegal.

The people of Arizona took advantage of the Department of Health’s qualifying condition appeal process in 2013 when they petitioned to include PTSD, migraines, and depression among the list of qualifying medical conditions. Following due process, the Director of the ADHS denied the petition.

prop 205 arizona

While it seemed like the Arizona population was becoming more tolerant of cannabis, it proved too soon to jump to recreational legalization. In 2016, Arizonans narrowly voted no on Prop 205 by a margin of 48:52, which would have legalized the adult use of marijuana. Ballotpedia attributes this loss to heavy early campaigning by opponents of recreational marijuana years before the election process. Opponents such as Insys, the creators of Fentanyl, lobbied heavily against recreational cannabis — their CBD medicine passed the first phases of FDA trials earlier in 2016. This loss resulted in a significant surge in new medical marijuana patients, many of whom were waiting to get their card only if the recreational law failed to pass.

Despite various lawmakers’ attempts to place limitations on Arizona’s medical marijuana law, the program is growing larger each year. As of late June 2017, there were 132,487 Arizona marijuana patients, 155 dispensary licenses (up from 124 at the law’s passage), and 881 patient caregivers.

The “Arizona Medical Marijuana Act”

The “Arizona Medical Marijuana Act,” or AMMA, empowers Arizona doctors to recommend medical marijuana as a viable treatment option for Arizona patients diagnosed with at least one qualifying medical condition. With this recommendation, a patient may apply for an Arizona Medical Marijuana Card, a card that allows patients to possess, purchase, and use medical marijuana.

2.5 oz of cannabis, up to 12 plants, deliveries of marijuana, 25 miles from a dispensary

Arizona marijuana patients or caregivers may possess up to 2.5 ounces of marijuana at any given time, and obtain 2.5 ounces in a 14-day period from an Arizona medical marijuana dispensary. Patients can also be authorized to grow up to 12 marijuana plants for their own use, or otherwise, find a caregiver to grow cannabis for them if they reside more than 25 miles from the nearest medical marijuana dispensary.

Living as a medical marijuana patient

chronic pain, alzheimers, cachxia, cancer, crohn's disease, glaucoma, hepatitis c, muscle spasms, nausea, ptsd, sclerosis, seizures, two or more conditions

For Arizonans like Brandi Atkins — mentioned at the beginning of this article — who think medical marijuana might be right for them, patients must receive a recommendation to use medical marijuana from a licensed Arizona physician. The patient must have one of the below qualifying medical conditions, and their physician must determine that the patient indeed has a qualifying condition. The written certification would state the doctor believes, in their professional opinion, the patient would likely receive therapeutic benefit from medical marijuana use.

Arizona’s list of debilitating qualifying conditions

ALS, alzheimer's disease, cancer, glaucoma, hiv/aids, hepatitis c, cachexia/wasting syndrome, muscle spasms, nausea, seizures, severe and chronic pain

Once a patient has received their written certification from an Arizona doctor, they may apply to the ADHS for a Registry Identification Card, a card that grants patients and caregivers the authority to possess, purchase, and use medical marijuana legally.

To apply for a Registry Identification Card, patients must submit their written certification, the application fee, their personal information, and a statement declaring they won’t use their medical marijuana for nefarious purposes (i.e. sell it to kids). If a minor wants to be a medical marijuana patient, there are stricter rules to follow before they can qualify for their card. The ADHS website explains the application process in more detail.

The most “caring” of the bunch

Some patients in critical need of cannabis are unable to travel easily to purchase or even consume cannabis without some assistance. Arizona included regulations to cover the people who would take care of these patients, known as Caregivers, allowing them to assist patients (up to five) in the medical use of marijuana.

Whether taking care of a child or an elderly parent, this endeavor is a huge responsibility. Caregivers need to educate themselves on the different aspects of marijuana, like different strains, consumption methods, and their patients’ specific health needs. Arizona caregivers must follow all the same regulations as patients, including registering with the ADHS and carrying an ID card.

Don’t worry, the law protects you!

As federal law still classifies marijuana as a Schedule 1 drug (without medicinal value), Prop 203 and other medical cannabis laws were designed to protect citizens’ rights. Arizona medical marijuana patients are supposed to be treated like every other resident. The AMMA’s regulations protect the rights of patients and caregivers in certain circumstances:

  • A school or landlord may not refuse to enroll/lease to a qualifying patient unless failing to do so would incur ramifications under federal law.
  • Medical facilities cannot deny treatment to patients based on their status as a medical marijuana user.
  • Parental rights cannot be denied based on a parent’s status as an Arizona medical marijuana patient.

While these protections are essential, they do not provide for every eventuality. Employers may not discriminate against employees who are medical marijuana patients, and may not penalize them for a positive drug test. However, employees cannot use or possess marijuana during the hours of work. Employers may lawfully discipline and even terminate any employee who tests positive for marijuana if they used or possessed during work hours, even if the employee is a registered patient.

Despite nearly 20 years of progress toward decriminalization and regulation, Arizona is still one of the toughest states in the nation when it comes to marijuana. Even minor possession is a felony for those who aren’t medical marijuana patients, with a max sentence of 3.75 years and a $150,000 fine.

I’m a physician, what part do I play in medical marijuana?

I have found in my study of these patients that Cannabis is really a safe, effective and non-toxic alternative to many standard medications.” -Philip Denney, MD, Testimony to the Arkansas legislature in support of House Bill 1303, “An Act to Permit the Medical Use of Marijuana,” Nov. 17, 2005.

Doctors are the gatekeepers to medical marijuana. In all medically legal states, doctors must fully evaluate their patients and determine whether cannabis is a fit for their medical needs and whether they have a qualifying condition. This places a lot of responsibility on doctors’ shoulders, which most Arizona doctors bear with professionalism and true concern for their patients. The physician must be a doctor of medicine, a doctor of osteopathic medicine, a naturopathic physician, or a homeopathic physician who holds a valid license to practice in Arizona.

medical marijuana doctors in arizona

Physicians meet patients, either in person or via telemedicine services, to determine if the patient has a qualifying condition before signing a written certification stating that, in their professional opinion, the patient has a qualifying condition and would likely receive therapeutic benefits from medical marijuana use.

However, Arizona courts have cracked down on some physicians who have turned their practices into “certification mills” due to their being no additional requirements for marijuana recommendations other than holding a valid license to practice medicine in Arizona.

Visiting from out of state?

Arizona allows non-Arizona medical marijuana patients the same rights and protections as Arizona citizens. This caveat makes sense … sort of.

The law states a Registry Identification Card, or its equivalent, issued by another state is valid in Arizona, except in that a visiting qualifying patient may not obtain marijuana from an Arizona marijuana dispensary.

This is a bit paradoxical. How is an out-of-state patient to access medical marijuana without purchasing from a dispensary or bringing it over state lines, which is federally illegal? Here’s how:

Another registered Arizona patient or designated caregiver can offer and provide medical marijuana so long as nothing of value is given in return, and the recipient doesn’t end up possessing more than 2.5 oz. of marijuana. This works, though it may be simpler to become a resident of Arizona.

Medical Marijuana Dispensary basics, keeping patients safe, obeying laws

inside a dispensary

All Arizona marijuana dispensaries are nonprofit organizations, a philosophy similar to out-of-state patients: “nothing of value may be exchanged for the transfer of medical marijuana.” While medical marijuana isn’t free, dispensaries may charge for medical marijuana as part of the expenses incurred during business operations. Patients can purchase up to 2.5 ounces of marijuana every two weeks, either as flower or an equivalent amount in concentrate, edibles, or other cannabis product forms.

As marijuana is still federally illegal (and valuable), security remains a  top priority. Dispensaries are required to use the ADHS online verification system to confirm each Arizona marijuana patient’s status as a patient and the amount of marijuana purchased over the last 60 days. This system is password protected and will not allow any access through an unencrypted internet connection. This online system does not include patients’ addresses or other personal information.

Dispensaries are also required to have a strong security system for their facility, including a single secure entrance. Medicating on the premises is forbidden. These heavy requirements go hand-in-hand with Arizona officials’ concern that marijuana products will encourage theft, violence, or negligent/illegal use.

Don’t be afraid to ask about the future

Though Arizona’s medical marijuana laws are full of sticky, complicated red tape, the program’s existence is still a huge step forward in the crusade for national legalization. Suffering patients in Arizona can find medical relief with our favorite plant and still enjoy protection from the law. Hopefully, after reading our guide, you now understand the nuts and bolts of how medical marijuana regulations work in Arizona.

Still want more information? Check out the Arizona Department of Health Services website at www.azdhs.gov.




















Start a Marijuana Business Today: CertificationClinics.com™ offers a comprehensive business model for recommending Medical Marijuana Certifications and/or Dispensary Ownership in your area. The CertificationClinics.com™ Business Support staff will educate you in every of the growing medical marijuana industry, providing you a fully operational and profitable enterprise. Learn More »